TY - JOUR
T1 - International comparisons of laboratory values from the 4CE collaborative to predict COVID-19 mortality
AU - Weber, Griffin M.
AU - Hong, Chuan
AU - Xia, Zongqi
AU - Palmer, Nathan P.
AU - Avillach, Paul
AU - L’Yi, Sehi
AU - Keller, Mark S.
AU - Murphy, Shawn N.
AU - Gutiérrez-Sacristán, Alba
AU - Bonzel, Clara Lea
AU - Serret-Larmande, Arnaud
AU - Neuraz, Antoine
AU - Omenn, Gilbert S.
AU - Visweswaran, Shyam
AU - Klann, Jeffrey G.
AU - South, Andrew M.
AU - Loh, Ne Hooi Will
AU - Cannataro, Mario
AU - Beaulieu-Jones, Brett K.
AU - Bellazzi, Riccardo
AU - Agapito, Giuseppe
AU - Alessiani, Mario
AU - Aronow, Bruce J.
AU - Bell, Douglas S.
AU - Benoit, Vincent
AU - Bourgeois, Florence T.
AU - Chiovato, Luca
AU - Cho, Kelly
AU - Dagliati, Arianna
AU - DuVall, Scott L.
AU - Barrio, Noelia García
AU - Hanauer, David A.
AU - Ho, Yuk Lam
AU - Holmes, John H.
AU - Issitt, Richard W.
AU - Liu, Molei
AU - Luo, Yuan
AU - Lynch, Kristine E.
AU - Maidlow, Sarah E.
AU - Malovini, Alberto
AU - Mandl, Kenneth D.
AU - Mao, Chengsheng
AU - Matheny, Michael E.
AU - Moore, Jason H.
AU - Morris, Jeffrey S.
AU - Morris, Michele
AU - Mowery, Danielle L.
AU - Ngiam, Kee Yuan
AU - Chen, Jin
AU - Kavuluru, Ramakanth
N1 - Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Given the growing number of prediction algorithms developed to predict COVID-19 mortality, we evaluated the transportability of a mortality prediction algorithm using a multi-national network of healthcare systems. We predicted COVID-19 mortality using baseline commonly measured laboratory values and standard demographic and clinical covariates across healthcare systems, countries, and continents. Specifically, we trained a Cox regression model with nine measured laboratory test values, standard demographics at admission, and comorbidity burden pre-admission. These models were compared at site, country, and continent level. Of the 39,969 hospitalized patients with COVID-19 (68.6% male), 5717 (14.3%) died. In the Cox model, age, albumin, AST, creatine, CRP, and white blood cell count are most predictive of mortality. The baseline covariates are more predictive of mortality during the early days of COVID-19 hospitalization. Models trained at healthcare systems with larger cohort size largely retain good transportability performance when porting to different sites. The combination of routine laboratory test values at admission along with basic demographic features can predict mortality in patients hospitalized with COVID-19. Importantly, this potentially deployable model differs from prior work by demonstrating not only consistent performance but also reliable transportability across healthcare systems in the US and Europe, highlighting the generalizability of this model and the overall approach.
AB - Given the growing number of prediction algorithms developed to predict COVID-19 mortality, we evaluated the transportability of a mortality prediction algorithm using a multi-national network of healthcare systems. We predicted COVID-19 mortality using baseline commonly measured laboratory values and standard demographic and clinical covariates across healthcare systems, countries, and continents. Specifically, we trained a Cox regression model with nine measured laboratory test values, standard demographics at admission, and comorbidity burden pre-admission. These models were compared at site, country, and continent level. Of the 39,969 hospitalized patients with COVID-19 (68.6% male), 5717 (14.3%) died. In the Cox model, age, albumin, AST, creatine, CRP, and white blood cell count are most predictive of mortality. The baseline covariates are more predictive of mortality during the early days of COVID-19 hospitalization. Models trained at healthcare systems with larger cohort size largely retain good transportability performance when porting to different sites. The combination of routine laboratory test values at admission along with basic demographic features can predict mortality in patients hospitalized with COVID-19. Importantly, this potentially deployable model differs from prior work by demonstrating not only consistent performance but also reliable transportability across healthcare systems in the US and Europe, highlighting the generalizability of this model and the overall approach.
UR - http://www.scopus.com/inward/record.url?scp=85131887608&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85131887608&partnerID=8YFLogxK
U2 - 10.1038/s41746-022-00601-0
DO - 10.1038/s41746-022-00601-0
M3 - Article
AN - SCOPUS:85131887608
SN - 2398-6352
VL - 5
JO - npj Digital Medicine
JF - npj Digital Medicine
IS - 1
M1 - 74
ER -